Terms of the agreement call for Inpharmatica to co-market its Blu-Chip probe-to-protein assignment module with Ingenuity's Pathway Analysis.
The alliance will enable researchers to move through two steps of analysis: probe assignment and protein network analysis, the companies said.
Details were not disclosed.